Literature DB >> 31124593

Vancomycin-loaded niosomes integrated within pH-sensitive in-situ forming gel for treatment of ocular infections while minimizing drug irritation.

Ayat Allam1, Mohamed A El-Mokhtar2, Mahmoud Elsabahy1,3,4.   

Abstract

OBJECTIVES: The aim of the current study was to minimize ocular irritation and prolong the pharmacological action of vancomycin via formulation into nanosized spherical niosomes loaded into pH-sensitive in-situ forming gel.
METHODS: Stability and rheological behaviour of the various gelling systems were evaluated. The ability of the selected system to eradicate methicillin-resistant Staphylococcus aureus (MRSA) infections was examined in vitro and in vivo. Draize technique was also used to assess ocular irritation in rabbits. KEY
FINDINGS: Nanosized spherical niosomes loaded with vancomycin at high entrapment efficiency were prepared and integrated into polymeric solution that forms gel in situ upon instillation into the eye, to allow for a further increase in the ocular residence time. In MRSA-infected rabbits, there were 180- and 2.5-fold increases in the antibacterial efficacy after treatment with the vancomycin niosomal gels in comparison with the untreated animals and the animals treated with the vancomycin free drug solution, respectively.
CONCLUSIONS: The developed formulations demonstrated promising in-vivo biocompatibility and antibacterial efficacy, signifying their potential application as ophthalmic preparation to overcome ocular infections induced by resistant bacterial strains while minimizing drug irritation and improving patient compliance.
© 2019 Royal Pharmaceutical Society.

Entities:  

Keywords:  zzm321990methicillin-resistant Staphylococcus aureuszzm321990; in-situ forming gel; niosomes; ocular infections; vancomycin

Mesh:

Substances:

Year:  2019        PMID: 31124593     DOI: 10.1111/jphp.13106

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  7 in total

1.  Development, characterization and in vitro-in vivo evaluation of Farnesol loaded niosomal gel for applications in oral candidiasis treatment.

Authors:  Tejas Barot; Deepak Rawtani; Pratik Kulkarni
Journal:  Heliyon       Date:  2021-09-11

2.  Development of Sedative Dexmedetomidine Sublingual In Situ Gels: In Vitro and In Vivo Evaluations.

Authors:  Ayat A Allam; Nermin E Eleraky; Nadeen H Diab; Mahmoud Elsabahy; Sahar A Mohamed; Hala S Abdel-Ghaffar; Nivin A Hassan; Samia A Shouman; Mervat M Omran; Sahar B Hassan; Noura G Eissa
Journal:  Pharmaceutics       Date:  2022-01-18       Impact factor: 6.321

Review 3.  Current Advances in Specialised Niosomal Drug Delivery: Manufacture, Characterization and Drug Delivery Applications.

Authors:  Bwalya A Witika; Kokoette E Bassey; Patrick H Demana; Xavier Siwe-Noundou; Madan S Poka
Journal:  Int J Mol Sci       Date:  2022-08-26       Impact factor: 6.208

Review 4.  Recent Advances in the Development of In Situ Gelling Drug Delivery Systems for Non-Parenteral Administration Routes.

Authors:  Barbara Vigani; Silvia Rossi; Giuseppina Sandri; Maria Cristina Bonferoni; Carla M Caramella; Franca Ferrari
Journal:  Pharmaceutics       Date:  2020-09-10       Impact factor: 6.321

Review 5.  Nano-Based Drug Delivery System: Recent Strategies for the Treatment of Ocular Disease and Future Perspective.

Authors:  Zufika Qamar; Farheen Fatima Qizilbash; Mohammad Kashif Iqubal; Asgar Ali; Jasjeet Kaur Narang; Javed Ali; Sanjula Baboota
Journal:  Recent Pat Drug Deliv Formul       Date:  2019

6.  Tailoring of Novel Azithromycin-Loaded Zinc Oxide Nanoparticles for Wound Healing.

Authors:  Mohammed S Saddik; Mahmoud M A Elsayed; Mohamed A El-Mokhtar; Haitham Sedky; Jelan A Abdel-Aleem; Ahmed M Abu-Dief; Mostafa F Al-Hakkani; Hazem L Hussein; Samah A Al-Shelkamy; Fatma Y Meligy; Ali Khames; Heba A Abou-Taleb
Journal:  Pharmaceutics       Date:  2022-01-05       Impact factor: 6.321

Review 7.  Lipid-Based Nanovesicular Drug Delivery Systems.

Authors:  Tania Limongi; Francesca Susa; Monica Marini; Marco Allione; Bruno Torre; Roberto Pisano; Enzo di Fabrizio
Journal:  Nanomaterials (Basel)       Date:  2021-12-14       Impact factor: 5.076

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.